Imran Talat 4
4 · Rani Therapeutics Holdings, Inc. · Filed Mar 29, 2023
Insider Transaction Report
Form 4
Imran Talat
DirectorChief Executive Officer
Transactions
- Award
Class A Common Stock
2023-03-27+353,500→ 444,445 total - Award
Stock Option (Right to Buy)
2023-03-27+575,600→ 575,600 totalExercise: $5.44Exp: 2033-03-26→ Class A Common Stock (575,600 underlying)
Footnotes (3)
- [F1]The shares subject to the restricted stock unit grant vest as follows: 1/16th of the RSUs shall vest quarterly over four years from March 27, 2023.
- [F2]Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F3]The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023.